Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive malignant tumor of mesothelial origin that shows a limited response to conventional chemotherapy and radiotherapy. Therefore, diagnosing MPM early is very important. Some researchers have previously reported that high-mobility group b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Chiharu, Shibata, Eisuke, Tabata, Rie, Kanemura, Shingo, Mikami, Koji, Nogi, Yoshitaka, Masachika, Eriko, Nishizaki, Tomoyuki, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644247/
https://www.ncbi.nlm.nih.gov/pubmed/23617783
http://dx.doi.org/10.1186/1471-2407-13-205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644247/
https://www.ncbi.nlm.nih.gov/pubmed/23617783
http://dx.doi.org/10.1186/1471-2407-13-205

Ejemplares similares